PROCTER & GAMBLE CoPG

Procter & Gamble expanded its operating income by 10% to $20.5 billion in FY2025, even as top-line sales posted a mere 0.3% increase. This divergence highlights the consumer giant's immense pricing power and cost discipline, proving its ability to manufacture bottom-line profitability in stagnant volume environments.

Top-line momentum steadily decelerated over the last half-decade, though overall revenue grew from $76.1 billion in FY2021 to $84.3 billion in FY2025. The company offset foreign exchange drag and flatlining unit volumes through aggressive pricing actions and manufacturing productivity savings. P&G consistently generated massive liquidity, maintaining an adjusted free cash flow productivity rate that regularly exceeded 90%. In FY2025, the company generated $14.6 billion in adjusted free cash flow. This cash engine funds relentless capital distribution, stretching from a combined $19.3 billion in dividends and share repurchases during FY2021 to an active $5 billion share reduction target for FY2026.

Investors have historically paid a premium for this defensive consistency. At the close of FY2025, the stock traded at $159.32, commanding a 24.5x price-to-earnings multiple based on an EPS of $6.51. Even as the business absorbs a new $1.5 billion to $2.0 billion restructuring plan aimed at trimming up to 7,000 non-manufacturing roles, the underlying margin profile remains heavily insulated by structural pricing advantages.